• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

FDA Clears Catheter with Integrated Intravascular Ultrasound Technology


Combining a support crossing catheter with intravascular ultrasound imaging, the Provisio SLT IVUS System offers simultaneous real-time visualization and measurement of vessel lumen.

The Food and Drug Administration (FDA) has granted 510(k) clearance for the Provisio SLT IVUS System, which features a support crossing catheter that integrates intravascular ultrasound, enabling clinicians to assess blood vessel lumen and obtain vessel measurements at the same time through Sonic Lumen Tomography (SLT).

Provisio Medical , the manufacturer of the Proviso SLT IVUS System, said the Provisio SLT IVUS System’s inclusion of the SLT IVUS Support Crossing Catheter provides dual functionality in interventional procedures with an ultrasound transducer array at the distal end of the catheter.

FDA Clears Catheter with Integrated Intravascular Ultrasound Technology

Through the use of Sonic Lumen Tomography (SLT), the newly FDA-cleared Provisio SLT IVUS System provides clinicians with simultaneous real-time visualization and measurement of vessel lumen during interventional procedures for patients with peripheral vascular disease. (Image courtesy of Provisio Medical.)

Incorporating intravascular ultrasound capability into a front-line support crossing catheter may help simplify workflows, reduce iodinated contrast media (ICM) and reduce radiation exposure for patients being treated for peripheral vascular disease (PVD), according to Provisio Medical.

"Clinical outcomes in peripheral vascular disease have consistently been shown to benefit from accurate intravascular measurements, yet adoption has been limited by the additional procedure time and training required to interpret images" noted S. Eric Ryan, M.D., the chief executive officer of Provisio Medical. "Thanks to the ease-of-use of SLT IVUS, which can be incorporated more efficiently in the peripheral vascular workflow, we believe there is the possibility of increased adoption and therefore improved outcomes for many more patients with potentially devastating peripheral vascular disease."

Related Videos
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Related Content
© 2024 MJH Life Sciences

All rights reserved.